STAT+: Cochrane review reignites Alzheimer’s amyloid wars
Another Elevidys trial, FDA reconsiders peptides, and other biotech news from The Readout
Another Elevidys trial, FDA reconsiders peptides, and other biotech news from The Readout
The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain peptides
Revolution Medicines $2B fundraise, Structure's new hire hints at acquisition efforts, and more Readout biotech news
The FDA asked Eli Lilly for more data on liver injury linked to its newly approved obesity pill, Foundayo
When scientific journals publish expressions of concerns, they have an obligation to do so prominently, Ed Silverman writes.
The key health care issues we're watching as Congress returns from recess.
Ben Sasse on enrolling in Rev Med's drug trial, more ADC investment, and other biotech news from The Readout
The FDA told more than 2,200 companies and researchers that they are required to report clinical trial results, or they may face fines
New Delhi: A Parliamentary Standing Committee on Health has recommended ensuring uniformity in faculty-student and patient-student ratios across all medical institutes, irrespective of ownership.In its 172nd report, the Department-related Parliamentary…
The National Commission for Allied and Healthcare Professions (NCAHP) has released curricula for 17 allied health courses and directed institutions to implement them mandatorily from the 2026-27 academic year.Sharing the…